Arca Biopharma | ABIO - Operating Expenses


Arca Biopharma reported $36.43M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Amgen USD 11.69B 6.9B Jun/2026
Arca Biopharma USD 36.43M 2M Mar/2026
Biogen USD 2.98B 1.02B Jun/2026
Brainstorm Cell Therapeutics USD 2.05M 198K Mar/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cipla INR 62.31B 3.04B Jun/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.19M 96K Mar/2026
CSL USD 5.7B 2.82B Dec/2025
Cytokinetics USD 207.8M 7.22M Jun/2026
Daiichi Sankyo JPY 489.64B 21.08B Jun/2026
Gilead Sciences USD 3.95B 19.57B Jun/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
Grifols EUR 1.99B 217.4M Dec/2025
Laboratory Of America USD 3.27B 146.9M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Otsuka Holdings JPY 561.64B 49.51B Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026